If you see a OTC Pharmaceutical company that doesn't report to the SEC - you better run because it is a guaranteed scam.
The cost of obtaining a patent from the USPTO is minimal. As many don't seem to understand a drug patent is worthless until it passed FDA approved clinical trials and that is costly and OTC companies don't have access to the capital needed to complete the clinical trials.
Also, 95-97% of all patents don't have any commercial value. The ENZC patents were granted in 2007 and 2011 and they haven't generated any revenue.
And most if not all ENZC shareholders don't understand that a PCT Patent is meaningless - in the US you still have to apply to the USPTO and apply for a non-provisional patent which means you have to supply prior art etc.
But you don't have to have a patent to start clinical trials which protects your drug. And many pharmaceutical companies pursue a patent at the same time they are doing clinical trials.
When the SAGA deal was announced the shareholders were so giddy - but I warned everyone that it was a fake deal and would never come to fruition.
News 
Market Data 
Discover 
AI
